Cargando…

JAK‐STAT core cancer pathway: An integrative cancer interactome analysis

Through a comprehensive review and in silico analysis of reported data on STAT‐linked diseases, we analysed the communication pathways and interactome of the seven STATs in major cancer categories and proposed rational targeting approaches for therapeutic intervention to disrupt critical pathways an...

Descripción completa

Detalles Bibliográficos
Autores principales: Erdogan, Fettah, Radu, Tudor Bogdan, Orlova, Anna, Qadree, Abdul Khawazak, de Araujo, Elvin Dominic, Israelian, Johan, Valent, Peter, Mustjoki, Satu M., Herling, Marco, Moriggl, Richard, Gunning, Patrick Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8980946/
https://www.ncbi.nlm.nih.gov/pubmed/35229974
http://dx.doi.org/10.1111/jcmm.17228
_version_ 1784681502517231616
author Erdogan, Fettah
Radu, Tudor Bogdan
Orlova, Anna
Qadree, Abdul Khawazak
de Araujo, Elvin Dominic
Israelian, Johan
Valent, Peter
Mustjoki, Satu M.
Herling, Marco
Moriggl, Richard
Gunning, Patrick Thomas
author_facet Erdogan, Fettah
Radu, Tudor Bogdan
Orlova, Anna
Qadree, Abdul Khawazak
de Araujo, Elvin Dominic
Israelian, Johan
Valent, Peter
Mustjoki, Satu M.
Herling, Marco
Moriggl, Richard
Gunning, Patrick Thomas
author_sort Erdogan, Fettah
collection PubMed
description Through a comprehensive review and in silico analysis of reported data on STAT‐linked diseases, we analysed the communication pathways and interactome of the seven STATs in major cancer categories and proposed rational targeting approaches for therapeutic intervention to disrupt critical pathways and addictions to hyperactive JAK/STAT in neoplastic states. Although all STATs follow a similar molecular activation pathway, STAT1, STAT2, STAT4 and STAT6 exert specific biological profiles associated with a more restricted pattern of activation by cytokines. STAT3 and STAT5A as well as STAT5B have pleiotropic roles in the body and can act as critical oncogenes that promote many processes involved in cancer development. STAT1, STAT3 and STAT5 also possess tumour suppressive action in certain mutational and cancer type context. Here, we demonstrated member‐specific STAT activity in major cancer types. Through systems biology approaches, we found surprising roles for EGFR family members, sex steroid hormone receptor ESR1 interplay with oncogenic STAT function and proposed new drug targeting approaches of oncogenic STAT pathway addiction.
format Online
Article
Text
id pubmed-8980946
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-89809462022-04-11 JAK‐STAT core cancer pathway: An integrative cancer interactome analysis Erdogan, Fettah Radu, Tudor Bogdan Orlova, Anna Qadree, Abdul Khawazak de Araujo, Elvin Dominic Israelian, Johan Valent, Peter Mustjoki, Satu M. Herling, Marco Moriggl, Richard Gunning, Patrick Thomas J Cell Mol Med Original Articles Through a comprehensive review and in silico analysis of reported data on STAT‐linked diseases, we analysed the communication pathways and interactome of the seven STATs in major cancer categories and proposed rational targeting approaches for therapeutic intervention to disrupt critical pathways and addictions to hyperactive JAK/STAT in neoplastic states. Although all STATs follow a similar molecular activation pathway, STAT1, STAT2, STAT4 and STAT6 exert specific biological profiles associated with a more restricted pattern of activation by cytokines. STAT3 and STAT5A as well as STAT5B have pleiotropic roles in the body and can act as critical oncogenes that promote many processes involved in cancer development. STAT1, STAT3 and STAT5 also possess tumour suppressive action in certain mutational and cancer type context. Here, we demonstrated member‐specific STAT activity in major cancer types. Through systems biology approaches, we found surprising roles for EGFR family members, sex steroid hormone receptor ESR1 interplay with oncogenic STAT function and proposed new drug targeting approaches of oncogenic STAT pathway addiction. John Wiley and Sons Inc. 2022-03-01 2022-04 /pmc/articles/PMC8980946/ /pubmed/35229974 http://dx.doi.org/10.1111/jcmm.17228 Text en © 2022 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Erdogan, Fettah
Radu, Tudor Bogdan
Orlova, Anna
Qadree, Abdul Khawazak
de Araujo, Elvin Dominic
Israelian, Johan
Valent, Peter
Mustjoki, Satu M.
Herling, Marco
Moriggl, Richard
Gunning, Patrick Thomas
JAK‐STAT core cancer pathway: An integrative cancer interactome analysis
title JAK‐STAT core cancer pathway: An integrative cancer interactome analysis
title_full JAK‐STAT core cancer pathway: An integrative cancer interactome analysis
title_fullStr JAK‐STAT core cancer pathway: An integrative cancer interactome analysis
title_full_unstemmed JAK‐STAT core cancer pathway: An integrative cancer interactome analysis
title_short JAK‐STAT core cancer pathway: An integrative cancer interactome analysis
title_sort jak‐stat core cancer pathway: an integrative cancer interactome analysis
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8980946/
https://www.ncbi.nlm.nih.gov/pubmed/35229974
http://dx.doi.org/10.1111/jcmm.17228
work_keys_str_mv AT erdoganfettah jakstatcorecancerpathwayanintegrativecancerinteractomeanalysis
AT radutudorbogdan jakstatcorecancerpathwayanintegrativecancerinteractomeanalysis
AT orlovaanna jakstatcorecancerpathwayanintegrativecancerinteractomeanalysis
AT qadreeabdulkhawazak jakstatcorecancerpathwayanintegrativecancerinteractomeanalysis
AT dearaujoelvindominic jakstatcorecancerpathwayanintegrativecancerinteractomeanalysis
AT israelianjohan jakstatcorecancerpathwayanintegrativecancerinteractomeanalysis
AT valentpeter jakstatcorecancerpathwayanintegrativecancerinteractomeanalysis
AT mustjokisatum jakstatcorecancerpathwayanintegrativecancerinteractomeanalysis
AT herlingmarco jakstatcorecancerpathwayanintegrativecancerinteractomeanalysis
AT morigglrichard jakstatcorecancerpathwayanintegrativecancerinteractomeanalysis
AT gunningpatrickthomas jakstatcorecancerpathwayanintegrativecancerinteractomeanalysis